GEOapplication/xmlftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE318nnn/GSE318830/primaryOK200TranscriptomicsHomo sapiensExpression profiling by high throughput sequencinghttps://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318830GEOGSEfalseLncRNA NAS1 deficiency drives cisplatin resistance in non-small cell lung cancerCisplatin resistance remains a major obstacle in non-small cell lung cancer (NSCLC) treatment. Long non-coding RNAs (lncRNAs) have been implicated in chemotherapy resistance, yet their specific roles and mechanisms are not fully understood. This study reveals that low expression of lncRNA NAS1 drives cisplatin resistance via NR2F1-mediated TGFB1/NF-κB signaling in NSCLC.2026/02/13GSE318830GSM9504119GSM9504121GSM9504120GSM9504112GSM9504111GSM9504122GSM9504114GSM9504113GSM9504116GSM9504115GSM9504118GSM950411724676318830Homo sapiens